IGFBP-7
Aliases: | AGM, FSTL2, IBP-7, IGFBP-7, IGFBP-7v, IGFBPRP1, MAC25, PSF, RAMSVPS, TAF |
---|---|
Other: | insulin-like growth factor-binding protein 7|IGF-binding protein 7|IGFBP-rP1|PGI2-stimulating factor|angiomodulin|prostacyclin-stimulating factor|tumor-derived adhesion factor |
This gene encodes a member of the insulin-like growth factor (IGF)-binding protein (IGFBP) family. IGFBPs bind IGFs with high affinity, and regulate IGF availability in body fluids and tissues and modulate IGF binding to its receptors. This protein binds IGF-I and IGF-II with relatively low affinity, and belongs to a subfamily of low-affinity IGFBPs. It also stimulates prostacyclin production a... see more
Alexa Fluor 647
Common Laser: | 628-640 |
---|---|
Common Filter: | 660/20 |
Excitation Peak: | 650 |
Emission Peak: | 665 |
Alexa Fluor™ 647 (AF647, Alexa 647) has an excitation peak at 650 nm and an emission peak at 665 nm, and is spectrally similar to Cy®5 (GE Healthcare), iFluor® 647 (ATT Bioquest), and DyLight™ 650 (Thermo Fisher Scientific). Alexa 647 is commonly used for flow cytometry, microscopy, super-resolution microscopy applications. It is very bright, photostable, and pH insensitive, all of which co... see more
Popular IGFBP-7 Alexa Fluor 647 Antibodies
Company / SKU |
Applications | Marker / Reactivity |
Host / Isotype / Clone |
Size / Price |
Details | |
---|---|---|---|---|---|---|
Novus Biologicals, a Bio-Techne brand NBP2-90174AF647 |
ELISA,ICC/IF | IGFBP-7 Human |
Rabbit IgG 3 |
0.1 ml $518 |
Details | |
Novus Biologicals, a Bio-Techne brand NBP2-90175AF647 |
WB | IGFBP-7 Human |
Rabbit IgG 65 |
100 μl $449 |
Details | |
Novus Biologicals, a Bio-Techne brand NBP2-12368AF647 |
WB | IGFBP-7 Human |
Mouse IgG1 MM0346-3N37 |
100 μl $479 |
Details | |
Bioss bs-5098R-A647 |
IHC-P | IGFBP-7 Human,Mouse,Rat |
Rabbit IgG |
100 μl $468 |
Details | |
Novus Biologicals, a Bio-Techne brand NBP2-90176AF647 |
IHC,IHC-P | IGFBP-7 Human |
Rabbit IgG 115 |
0.1 ml $549 |
Details | |
Browse IGFBP-7 / Alexa Fluor 647 antibodies. |